Regulatory BPC-157: Experimental Peptide Prohibited USADA frames BPC-157 as an experimental peptide prohibited under WADA's S0 unapproved-substances category
Copper toxicity typically occurs with chronic intake above 1015mg daily over months, presenting as gastrointestinal distress, hepatic dysfunction, or zinc depletion
Fungal imbalances likely occur in small bowel/proximal colon, not detected in distal colon stool samples
This endogenous presence provides a baseline safety context
Call 1-800-537-0411 Monday - Friday from 9:00 a.m
By influencing gut barrier integrity, vascular health, and inflammation levels, BPC-157 offers a targeted approach to repairing the gut lining especially when conventional supplements like probiotics or glutamine fall short